financetom
Forex World Market Business Cryptocurrency Commodities MAP
financetom
Business
financetom
/
Business
/
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug
May 26, 2025 10:35 AM

(Reuters) -Pfizer ( PFE ) has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc ( TRSBF ) for the development, manufacturing and commercialization of a drug undergoing trials for treatment of certain types of cancer and tumours, the U.S. drugmaker said on Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Accenture names Angie Park as new CFO
Accenture names Angie Park as new CFO
Jun 11, 2024
June 11 (Reuters) - Accenture ( ACN ) said on Tuesday that Angie Park, currently leading its Business and Commercial Finance division, will take on the role of the company's CFO on December 1. ...
 Rubrik Fiscal Q1 Loss Widens, Revenue Increases; Q2, Fiscal 2025 Outlook Issued -- Shares Rise After Hours
Rubrik Fiscal Q1 Loss Widens, Revenue Increases; Q2, Fiscal 2025 Outlook Issued -- Shares Rise After Hours
Jun 11, 2024
04:41 PM EDT, 06/11/2024 (MT Newswires) -- Rubrik ( RBRK ) reported a fiscal Q1 non-GAAP loss late Tuesday of $1.58 per diluted share, wider than a loss of $1.48 a year earlier. Analysts polled by Capital IQ expected a loss of $1.73. Revenue for the quarter ended April 30 rose to $187.3 million from $135.7 million a year earlier....
 Cogent Communications Holdings Insider Bought Shares Worth $526,130, According to a Recent SEC Filing
Cogent Communications Holdings Insider Bought Shares Worth $526,130, According to a Recent SEC Filing
Jun 11, 2024
04:41 PM EDT, 06/11/2024 (MT Newswires) -- Marc Montagner, Director, on June 11, 2024, executed a purchase for 10,000 shares in Cogent Communications Holdings ( CCOI ) for $526,130. Following the Form 4 filing with the SEC, Montagner has control over a total of 79,468 shares of the company, with 79,468 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1158324/000141588924016367/xslF345X03/form4-06112024_080649.xml Price: 52.54, Change:...
 Protagonist Therapeutics Insider Sold Shares Worth $1,231,650, According to a Recent SEC Filing
Protagonist Therapeutics Insider Sold Shares Worth $1,231,650, According to a Recent SEC Filing
Jun 11, 2024
04:37 PM EDT, 06/11/2024 (MT Newswires) -- Dinesh V Patel, Director, President and CEO, on June 07, 2024, sold 35,000 shares in Protagonist Therapeutics ( PTGX ) for $1,231,650. Following the Form 4 filing with the SEC, Patel has control over a total of 515,415 shares of the company, with 515,415 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1377121/000110465924070419/xslF345X03/tm2416932-1_4seq1.xml Price: 35.97, Change:...
About
Terms and Conditions Privacy policy Cookie Settings Contact Us
Services
Login register
financetom Market Personal Finance Business Economy Cryptocurrency MAP
Links
zpostcode Recruit weather mreligion Yellowpages sport constellation shopping name game directory literature Word tour furnish Lottery tftnews lyrics News digital car dir Edu Finance
Copyright 2023-2026 - www.financetom.com All Rights Reserved